News
10-18-2023, 06:18 PM
Of the 198 new oncology drugs approved by the U.S. Food and Drug Administration (FDA) between 1998 and 2022, approximately 43% were precision oncology therapies, the use of which is guided by biomarker testing.
More... (https://www.news-medical.net/news/20231018/Precision-oncology-therapies-account-for-nearly-half-of-new-cancer-drug-approvals-since-1998.aspx)
More... (https://www.news-medical.net/news/20231018/Precision-oncology-therapies-account-for-nearly-half-of-new-cancer-drug-approvals-since-1998.aspx)